Schott Pharma & CO. (1SXP.XETRA) Q2 2024 Earnings

27JunConfirmed
Q4 2023
Q2 2024
0.17
0.21
0.25
0.3

Details

Expected EPS
0.20881231289542002
Actual EPS
0.16748089807982
Surprise EPS
-0.04
Surprise Percent
+19.79%

Description

Schott Pharma & CO. (1SXP.XETRA) has reported earnings of 0.16748089807982 per share for Q2 2024.

0 Comments

Share your thoughts